Life Science REIT plc (LON:LABS - Get Free Report) shot up 0.2% during trading on Thursday . The company traded as high as GBX 43.45 ($0.58) and last traded at GBX 42.70 ($0.57). 9,083,673 shares traded hands during mid-day trading, an increase of 745% from the average session volume of 1,075,304 shares. The stock had previously closed at GBX 42.60 ($0.56).
Life Science REIT Stock Performance
The company has a market cap of £156.22 million, a price-to-earnings ratio of -3.90 and a beta of 0.08. The company's 50 day moving average price is GBX 39.63 and its 200 day moving average price is GBX 38.70.
Life Science REIT (LON:LABS - Get Free Report) last announced its earnings results on Wednesday, April 16th. The company reported GBX 1.70 ($0.02) EPS for the quarter. Life Science REIT had a negative return on equity of 14.53% and a negative net margin of 198.99%.
About Life Science REIT
(
Get Free Report)
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.
See Also
Before you consider Life Science REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.
While Life Science REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
